You may be right Esh and they would not be breaching any ASX...

First 292 Last

Share
Profile

Follow
davmarc

1,098 Posts.

68

21/08/18

21:33

Post #: 35077043
Share

Originally posted by eshmun ↑

Has anyone considered that the company might be delaying the release of information while they negotiate to secure additional ground holdings.

It’s an interesting question in my opinion because it raises the question of where a director’s legal duties lie in the face of the listing rules and commercially sensitive information.

The directors have a duty under the ASX listing rules of continuous disclosure when it comes to information that by everyday interpretation has the potential to be price sensitive/moving but at the same time they have duties under the corporation law to act in the best interests of shareholders. If the ASX listing rules require that results are released which could potentially compromise commercial arrangements that are being made to secure the rights over neighbouring ground that those results point to as havimg significant value then there is an obvious contradiction in the way the laws operate. In this instance where commercial secrecy is involved I think that the director’s higher duty under the law is to the shareholders of the company not the rules imposed by the stock exchange.

Let’s put it more simply. If company X has secret Y which is price sensitive but by making secret Y public it significantly risks the commercial value of secret Y, what is a director to do?

I’m not saying this is the reason for the delay in information coming out but I think it’s a pertinent question to the situation the company finds itself in. Ideally you would want to keep all the drill results secret until you have secured any and all important surrounding exploration areas. Esh

Expand

You may be right Esh and they would not be breaching any ASX rules re disclosure if they where 'wharehousing' the cores for later assaying. It would be a different story if the lab had already assayed the material.

ADT Price at posting: 40.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

CHW

Cleo adds Royal Women's Hospital to its clinical trial for ovarian cancer diagnosis

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

There are more pages in this discussion • 35 more messages in this thread...

First 292 Last

Add ADT (ASX) to my watchlist

(20min delay)
Last $4.12		Change 0.020(0.49%)		Mkt cap ! $918.1M

Open	High	Low	Value	Volume
$4.10	$4.14	$4.10	$32.16K	7.84K

Buyers (Bids)

No.	Vol.	Price($)
4	1829	$4.11

Sellers (Offers)

Price($)	Vol.	No.
$4.12	773	3

View Market Depth

No.	Vol.	Price($)
1	1197	0.835
1	5000	0.815
3	9950	0.810
2	21000	0.805
6	46713	0.800

Price($)	Vol.	No.
0.840	40000	1
0.850	14746	1
0.860	9795	2
0.875	9168	2
0.880	17293	2

Last trade - 10.11am 27/11/2024 (20 minute delay)

ADT (ASX) Chart

You may be right Esh and they would not be breaching any ASX...

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Cleo adds Royal Women's Hospital to its clinical trial for ovarian cancer diagnosis

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Buyers (Bids)

Sellers (Offers)